Aeluma is trading at $17.27 (down 5.3%) as the stock undergoes consolidation following a significant multi-day surge.
- The recent rally was fueled by a July 29, 2026, Letter of Intent with the U.S. Department of Commerce for up to $30 million in CHIPS and Science Act R&D funding.
- Analysts view the August 5 pullback as short-term profit-taking after steep gains rather than a result of new negative company-specific developments.